Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients/Experiment 7

From BugSigDB


Reviewed Marked as Reviewed by Svetlana up on 2024-11-22

Curated date: 2024/11/21

Curator: Aleru Divine

Revision editor(s): Aleru Divine

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Surface of tongue Tongue surface,Surface of tongue,surface of tongue
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
COVID-19 2019 novel coronavirus,2019 novel coronavirus infection,2019-nCoV,2019-nCoV infection,beta-CoV,beta-CoVs,betacoronavirus,coronavirus disease 2019,SARS-coronavirus 2,SARS-CoV-2,severe acute respiratory syndrome coronavirus 2,severe acute respiratory syndrome coronavirus 2 infectious disease,β-coronavirus,β-CoV,β-CoVs,COVID-19,cOVID-19
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
Covid-19 Group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Participants in this group were Covid-19 patients from the test phase.
Group 0 sample size Number of subjects in the control (unexposed) group
88
Group 1 sample size Number of subjects in the case (exposed) group
48
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
8 weeks

Lab analysis

Sequencing type
ITS / ITS2
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Mann-Whitney (Wilcoxon)
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
3
Matched on Factors on which subjects have been matched on in a case-control study
age, sex

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Richness Number of species
increased

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2024-11-23

Curated date: 2024/11/21

Curator: Aleru Divine

Revision editor(s): Aleru Divine

Source: Figure 1E, F and Figure S3B

Description: The ten most abundant fungi among the differential fungi between COVID-19 and controls at the phylum, genus and species levels.

Abundance in Group 1: increased abundance in Covid-19 Group

NCBI Quality ControlLinks
Acrodictys
Acrodictys fluminicola
Candida
Candida albicans
Hydnobolites
Simplicillium
Simplicillium sympodiophorum
Zoopagomycota
Ascomycota

Revision editor(s): Aleru Divine

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2024-11-22

Curated date: 2024/11/21

Curator: Aleru Divine

Revision editor(s): Aleru Divine

Source: Figure 1E, F and Figure S3B

Description: The ten most abundant fungi among the differential fungi between COVID-19 and controls at the phylum, genus and species levels.

Abundance in Group 1: decreased abundance in Covid-19 Group

NCBI Quality ControlLinks
Arthrographis
Arthrographis grakistii
Cladosporium
Cladosporium kenpeggii
Cryptococcus
Diversispora
Diversispora spurca
Harringtonia lauricola
Malassezia
Malassezia restricta
Raffaelea
Vanrija longa
Zanclospora jonesii
Basidiomycota
Mucoromycota
Cryptomycota

Revision editor(s): Aleru Divine